Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

ACC 2024 Congress

Catch up on all the top stories and latest evidence in cardiology research with our ACC 2024 Congress hub page.
ADVANCED SEARCH
Log in
Top
General Thoracic and Cardiovascular Surgery
Published in: General Thoracic and Cardiovascular Surgery 5/2023

12-01-2023 | Soft Tissue Sarcoma | Review Article

Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors

Author: Daniel Shell

Published in: General Thoracic and Cardiovascular Surgery | Issue 5/2023

Login to get access

Abstract

Background

Metastatic sarcoma confers a grave prognosis to patients and poses a management dilemma for clinicians. Pulmonary metastasectomy is frequently performed for the recurrence of sarcomatous tumours in the lung, but the evidence-base is poor. No guidelines exist to inform clinicians on appropriate patient selection and surgical technique.

Aim

This review aims to establish and analyse the most important prognostic factors for survival post pulmonary metastasectomy for recurrent sarcoma. We summarise the key tumour, peri-operative and patient characteristics that should guide surgical management.

Methods

A comprehensive search of the literature utilising OVID Medline and PubMed databases was conducted to identify all relevant research within the past 15 years. We evaluated all articles that specifically studied sarcoma patients (both bone and soft tissue).

Conclusion

Disease-free interval and tumour burden remain important prognostic factors, while tumour grade is likely not significant. VATS is a safe and viable alternative to thoracotomy without sacrificing survival outcomes. No single peri-operative characteristic provides useful prognostic information in isolation.
Literature
1.
2.
3.
Omura A, Kimura T, Tanaka R, Hiroshima T, Maniwa T, Takenaka S, et al. Surgical indication of pulmonary metastasis arising from osteosarcoma or soft tissue sarcoma. Gen Thorac Cardiovasc Surg. 2022;70:273–9.PubMedCrossRef
4.
Kawamoto T, Hara H, Morishita M, Fukase N, Kawakami Y, Takemori T, et al. Prognostic influence of the treatment approach for pulmonary metastasis in patients with soft tissue sarcoma. Clin Exp Metastasis. 2020;37:509–17.PubMedCrossRef
5.
Treasure T, Møller H, Fiorentino F, Utley M. Editorial comment: Forty years on: pulmonary metastasectomy for sarcoma. Eur J Cardiothorac Surg. 2013;43:799–800.PubMedCrossRef
6.
Pastorino U, Buyse M, Friedel G, Ginsberg RJ, Girard P, Goldstraw P, et al. Long-term results of lung metastasectomy: Prognostic analyses based on 5206 cases. J Thorac Cardiovasc Surg. 1997;113:37–49.PubMedCrossRef
7.
Predina JD, Puc MM, Bergey MR, Sonnad SS, Kucharczuk JC, Staddon A, et al. Improved survival after pulmonary metastasectomy for soft tissue sarcoma. J Thorac Oncol. 2011;6:913–9.PubMedCrossRef
8.
Lee RM, Ethun CG, Gamboa AC, Turgeon MK, Tran T, Poultsides G, et al. A novel preoperative risk score to guide patient selection for resection of soft tissue sarcoma lung metastases: An analysis from the United States Sarcoma Collaborative. J Surg Oncol. 2021;124:1477–84.PubMedPubMedCentralCrossRef
9.
Özdil A, Tekneci AK, Dökümcü Z, Divarcı E, Keçeci B, Sezak M, et al. Pulmonary metastasectomy of sarcoma: is the ratio of surgical margin to nodule size a prognostic factor? Thorac Cardiovasc Surg. 2019;67:675–82.PubMedCrossRef
10.
Ahn Y, Lee SM, Kim MS, Choi S, Kim S, Do K-H, et al. Volume doubling times of pulmonary metastases in patients with bone and soft-tissue sarcomas: associations with subsequent new metastases and survival after metastasectomy. Am J Roentgenol. 2022;218:624–32.CrossRef
11.
Nakayama S, Kobayashi E, Nishio J, Toda Y, Yotsukura M, Watanabe S-I, et al. Prognostic factors of pulmonary metastasectomy for soft tissue sarcomas arising in the trunk wall and extremities. Cancers. 2022;14:3329.PubMedPubMedCentralCrossRef
12.
Treasure T, Farewell V, Macbeth F, Monson K, Williams NR, Brew-Graves C, et al. Pulmonary metastasectomy versus continued active monitoring in colorectal cancer (PulMiCC): a multicentre randomised clinical trial. Trials. 2019;20:718.PubMedPubMedCentralCrossRef
13.
Treasure T, Macbeth F. Doubt about effectiveness of lung metastasectomy for sarcoma. J Thorac Cardiovasc Surg. 2015;149:93–4.PubMedCrossRef
14.
Choi JH, Ro JY. The 2020 WHO classification of tumors of soft tissue: selected changes and new entities. Adv Anat Pathol. 2021;28:44–58.PubMedCrossRef
15.
Yamamoto H, Namba K, Yamamoto H, Toji T, Soh J, Shien K, et al. The neutrophil-to-lymphocyte ratio as a novel independent prognostic factor for multiple metastatic lung tumors from various sarcomas. Surg Today. 2021;51:127–35.PubMedCrossRef
16.
17.
Cheung F, Alam N, Wright G. Pulmonary metastasectomy: analysis of survival and prognostic factors in 243 patients. ANZ J Surg. 2018;88:1316–21.PubMedCrossRef
18.
Gusho CA, Seder CW, Lopez-Hisijos N, Blank AT, Batus M. Pulmonary metastasectomy in bone and soft tissue sarcoma with metastasis to the lung. Interact Cardiovasc Thorac Surg. 2021;33:879–84.PubMedPubMedCentralCrossRef
19.
Lin AY, Kotova S, Yanagawa J, Elbuluk O, Wang G, Kar N, et al. Risk stratification of patients undergoing pulmonary metastasectomy for soft tissue and bone sarcomas. J Thorac Cardiovasc Surg. 2015;149:85–92.PubMedCrossRef
20.
Salah S, Fayoumi S, Alibraheem A, Massad E, Abdel Jalil R, Yaser S, et al. The influence of pulmonary metastasectomy on survival in osteosarcoma and soft-tissue sarcomas: a retrospective analysis of survival outcomes, hospitalizations and requirements of home oxygen therapy. Interact Cardiovasc Thorac Surg. 2013;17:296–302.PubMedPubMedCentralCrossRef
21.
Lautz TB, Farooqui Z, Jenkins T, Heaton TE, Doski JJ, Cooke-Barber J, et al. Thoracoscopy vs thoracotomy for the management of metastatic osteosarcoma: a pediatric surgical oncology research collaborative study. Int J Cancer. 2021;148:1164–71.PubMedCrossRef
22.
Chudgar NP, Brennan MF, Tan KS, Munhoz RR, D’Angelo SP, Bains MS, et al. Is repeat pulmonary metastasectomy indicated for soft tissue sarcoma? Ann Thorac Surg. 2017;104:1837–45.PubMedPubMedCentralCrossRef
23.
Stanelle EJ, Christison-Lagay ER, Wolden SL, Meyers PA, Quaglia MPL. Pulmonary metastasectomy in pediatric/adolescent patients with synovial sarcoma: An institutional review. J Pediatr Surg. 2013;48:757–63.PubMedCrossRef
24.
Tetta C, Rocca M, Salone M, Longhi A, Ferrari C, Londero F, et al. Predictors of lung recurrence and disease-specific mortality after pulmonary metastasectomy for soft tissue sarcoma. Surg Oncol. 2021;37: 101532.PubMedCrossRef
25.
Sambri A, Rocca M, Tuzzato G, Donati DM, Bianchi G. Lung Metastasectomy improves survival in patients affected by grade 2 and 3 chondrosarcoma. Oncol Res Treat. 2020;43:134–9.PubMedCrossRef
26.
Kim S, Ott HC, Wright CD, Wain JC, Morse C, Gaissert HA, et al. Pulmonary resection of metastatic sarcoma: prognostic factors associated with improved outcomes. Ann Thorac Surg. 2011;92:1780–7.PubMedCrossRef
27.
Okiror L, Peleki A, Moffat D, Bille A, Bishay E, Rajesh P, et al. Survival following pulmonary metastasectomy for sarcoma. Thorac Cardiovasc Surg. 2016;64:146–9.PubMedCrossRef
28.
Matsumoto I, Oda M, Yachi T, Tsuchiya H, Zen Y, Watanabe G. Outcome prediction of pulmonary metastasectomy can be evaluated using metastatic lesion in osteosarcoma patients. World J Surg. 2013;37:1973–80.PubMedCrossRef
29.
Dossett LA, Toloza EM, Fontaine J, Robinson LA, Reed D, Druta M, et al. Outcomes and clinical predictors of improved survival in a patients undergoing pulmonary metastasectomy for sarcoma. J Surg Oncol. 2015;112:103–6.PubMedCrossRef
30.
Nakamura T, Matsumine A, Takao M, Nakatsuka A, Matsubara T, Asanuma K, et al. Impact of tumor volume doubling time on post-metastatic survival in bone or soft-tissue sarcoma patients treated with metastasectomy and/or radiofrequency ablation of the lung. OncoTargets Ther. 2017;10:559–64.CrossRef
31.
Toussi MS, Bagheri R, Dayani M, Anvari K, Sheibani S. Pulmonary metastasectomy and repeat metastasectomy for soft-tissue sarcoma. Asian Cardiovasc Thorac Ann. 2013;21:437–42.PubMedCrossRef
32.
Ohnstad HO, Bruland ØS, Taksdal I, Bjerkehagen B, Nenadovic M, Sæter G, et al. Response to preoperative chemotherapy in patients undergoing resection of pulmonary metastasis from soft tissue sarcoma – a predictor of outcome? Acta Oncol. 2014;53:1180–7.PubMedCrossRef
33.
Heaton TE, Hammond WJ, Farber BA, Pallos V, Meyers PA, Chou AJ, et al. A 20-year retrospective analysis of CT-based pre-operative identification of pulmonary metastases in patients with osteosarcoma: A single-center review. J Pediatr Surg. 2017;52:115–9.PubMedCrossRef
34.
Ahmed G, Elshafiey M, Romeih M, Elgammal A, Kamel A, Salama A, et al. Prognostic significance of the ratio of surgically resected to radiologically detected lung nodules in patients with metastatic osteosarcoma. Surg Oncol. 2022;40: 101701.PubMedCrossRef
35.
Pfannschmidt J, Klode J, Muley T, Dienemann H, Hoffmann H. Nodal involvement at the time of pulmonary metastasectomy: experiences in 245 patients. Ann Thorac Surg. 2006;81:448–54.PubMedCrossRef
36.
Krüger M, Schmitto JD, Wiegmann B, Rajab TK, Haverich A. Optimal timing of pulmonary metastasectomy – Is a delayed operation beneficial or counterproductive? Eur J Surg Oncol Elsevier. 2014;40:1049–55.CrossRef
37.
Dear RF, Kelly PJ, Wright GM, Stalley P, Mccaughan BC, Tattersall MH. Pulmonary metastasectomy for bone and soft tissue sarcoma in Australia: 114 patients from 1978 to 2008. Asia Pac J Clin Oncol. 2012;8:292–302.PubMedCrossRef
38.
Ahmed G, Zamzam M, Kamel A, Ahmed S, Salama A, Zaki I, et al. Effect of timing of pulmonary metastasis occurrence on the outcome of metastasectomy in osteosarcoma patients. J Pediatr Surg. 2019;54:775–9.PubMedCrossRef
39.
Stork T, Boemans R, Hardes J, Streitbürger A, Dirksen U, Pöttgen C, et al. Number of metastases and their response to chemotherapy impact survival of patients with isolated lung metastases from bone-derived sarcoma. BMC Cancer. 2021;21:375.PubMedPubMedCentralCrossRef
40.
Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, et al. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg. 2011;212:821–6.PubMedCrossRef
41.
Chudgar NP, Brennan MF, Munhoz RR, Bucciarelli PR, Tan KS, D’Angelo SP, et al. Pulmonary metastasectomy with therapeutic intent for soft-tissue sarcoma. J Thorac Cardiovasc Surg. 2017;154:319-330.e1.PubMedPubMedCentralCrossRef
42.
García Franco CE, Torre W, Tamura A, Guillén-Grima F, San-Julian M, Martin-Algarra S, et al. Long-term results after resection for bone sarcoma pulmonary metastases. Eur J Cardiothorac Surg. 2010;37:1205–8.PubMedCrossRef
43.
Mizuno T, Taniguchi T, Ishikawa Y, Kawaguchi K, Fukui T, Ishiguro F, et al. Pulmonary metastasectomy for osteogenic and soft tissue sarcoma: who really benefits from surgical treatment? Eur J Cardiothorac Surg. 2013;43:795–9.PubMedCrossRef
44.
Tanju S, Saricam M, Kaba E, Kapdagli M, Dilege S, Toker A. Factors associated with pulmonary recurrence after pulmonary metastasectomy for sarcomatous disease. Surg Today. 2014;44:914–8.PubMedCrossRef
45.
Reza J, Sammann A, Jin C, Horvai A, Hudnall M, Jablons DM, et al. Aggressive and minimally invasive surgery for pulmonary metastasis of sarcoma. J Thorac Cardiovasc Surg. 2014;147:1193–201.PubMedCrossRef
46.
Paramanathan A, Wright G. Pulmonary metastasectomy for sarcoma of gynaecologic origin. Heart Lung Circ. 2013;22:270–5.PubMedCrossRef
47.
Gossot D, Radu C, Girard P, Cesne AL, Bonvalot S, Boudaya MS, et al. Resection of pulmonary metastases from sarcoma: can some patients benefit from a less invasive approach? Ann Thorac Surg. 2009;87:238–43.PubMedCrossRef
48.
Predina JD, Newton A, Deshpande C, Low P, Singhal S. Utilization of targeted near-infrared molecular imaging to improve pulmonary metastasectomy of osteosarcomas. J Biomed Opt. 2018;23:1.PubMedCrossRef
49.
Predina JD, Newton AD, Corbett C, Shin M, Sulfyok LF, Okusanya OT, et al. Near-infrared intraoperative imaging for minimally invasive pulmonary metastasectomy for sarcomas. J Thorac Cardiovasc Surg. 2019;157:2061–9.PubMedCrossRef
50.
Rijs Z, Shifai AN, Bosma SE, Kuppen PJK, Vahrmeijer AL, Keereweer S, et al. Candidate biomarkers for specific intraoperative near-infrared imaging of soft tissue sarcomas: a systematic review. Cancers. 2021;13:557.PubMedPubMedCentralCrossRef
51.
Li Y, Zhang W, Li S, Tu C. Clinical efficiency of repeated pulmonary metastasectomy in sarcoma patients with recurrent pulmonary metastasis: A meta-analysis. J Cancer Res Ther. 2018;14:457.CrossRef
52.
Treasure T, Fiorentino F, Scarci M, Møller H, Utley M. Pulmonary metastasectomy for sarcoma: a systematic review of reported outcomes in the context of Thames Cancer Registry data. BMJ Open. 2012;2: e001736.PubMedPubMedCentralCrossRef
53.
Cariboni U, De Sanctis R, Giaretta M, Voulaz E, Morenghi E, Colombo P, et al. Survival outcome and prognostic factors after pulmonary metastasectomy in sarcoma patients: a 18-year experience at a single high-volume referral center. Am J Clin Oncol. 2019;42:6–11.PubMedCrossRef
54.
Balduyck B, Thielen JV, Cogen A, Hengst WD, Hendriks J, Lauwers P, et al. Quality of life evolution after pulmonary metastasectomy: a prospective study comparing isolated lung perfusion with standard metastasectomy. J Thorac Oncol. 2012;7:1567–73.PubMedCrossRef
55.
da Silva Sardenberg RA, de Figueiredo LP, Haddad FJ, Luiz Gross J, Younes RN. Pulmonary metastasectomy from soft tissue sarcomas. Clinics. 2010;65:871–6.PubMedCentralCrossRef
56.
Giuliano K, Sachs T, Montgomery E, Guzzetta A, Brock M, Pawlik TM, et al. Survival following lung metastasectomy in soft tissue sarcomas. Thorac Cardiovasc Surg. 2016;64:150–8.PubMedCrossRef
57.
Smith R, Pak Y, Kraybill W, Kane JM. Factors associated with actual long-term survival following soft tissue sarcoma pulmonary metastasectomy. Eur J Surg Oncol. 2009;35:356–61.PubMedCrossRef
58.
Takatsu F, Yamamoto H, Tomioka Y, Tanaka S, Shien K, Suzawa K, et al. Survival and prognostic factors in patients undergoing pulmonary metastasectomy for lung metastases from retroperitoneal sarcoma. World J Surg Oncol. 2022;20:114.PubMedPubMedCentralCrossRef
59.
Yamamoto Y, Kanzaki R, Kanou T, Ose N, Funaki S, Shintani Y, et al. Long-term outcomes and prognostic factors of pulmonary metastasectomy for osteosarcoma and soft tissue sarcoma. Int J Clin Oncol. 2019;24:863–70.PubMedCrossRef
Metadata
Title
Improving survival after pulmonary metastasectomy for sarcoma: analysis of prognostic factors
Author
Daniel Shell
Publication date
12-01-2023
Publisher
Springer Nature Singapore
Published in
General Thoracic and Cardiovascular Surgery / Issue 5/2023
Print ISSN: 1863-6705
Electronic ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-023-01905-y

Other articles of this Issue 5/2023

General Thoracic and Cardiovascular Surgery 5/2023 Go to the issue

Original Article

Long-term outcomes of combined pulmonary endarterectomy and additional balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension

Original Article

Shunt and pace: a novel experimental model of atrial fibrillation with a volume-loaded left atrium

Original Article

Number of dye marks required in virtual-assisted lung mapping

Original Article

The impact of prognostic nutrition index on the waitlist mortality of lung transplantation

Original Article

HMOX1 silencing prevents doxorubicin-induced cardiomyocyte injury, mitochondrial dysfunction, and ferroptosis by downregulating CTGF

How to Do It

Simplified primum ASD closure technique in complete VSD repair: shallow suture crossing on the AV node